Trials / Completed
CompletedNCT01212861
Surgical Treatment of Refractory Open Angle Glaucoma
Surgical Treatment of Refractory Open Angle Glaucoma - A Prospective, Open-Label, Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- iScience Interventional Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety, efficacy, and performance of the Suprachoroidal Dissection Instrument in creating a fistula between Schlemm's canal and the suprachoroidal space in refractory, open angle glaucoma subjects.
Detailed description
The Suprachoroidal Dissection Instrument (SDI) is a manually operated surgical instrument designed for use within Schlemm's canal. The instrument can access Schlemm's canal through a small ab-externo dissection, allowing use in eyes with scarring due to previous surgery or trauma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Suprachoroidal Dissection Instrument (SDI) | The Suprachoroidal Dissection Instrument (SDI) is a manually operated, non-powered, re-usable ophthalmic surgical instrument. The SDI is designed to enter a surgically exposed Schlemm's canal and be advanced up to 90 degrees around the canal from the entry site. |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2010-10-01
- Last updated
- 2012-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01212861. Inclusion in this directory is not an endorsement.